跟腱修復和重組市場規模、佔有率和趨勢分析 | 全球市場 | 2026–2032 | 包括移植物和縫合錨釘

2025年，全球阿基里斯腱修復重組市場規模接近2.6億美元。預計該市場將以3.8%的複合年成長率成長，到2032年將超過3.3億美元。

本報告涵蓋跟腱修復和重組手術中使用的移植物和縫合錨釘。根據器械類型，移植物分為同種異體移植物、異質骨移植和合成移植物。根據器械類型，縫合錨釘分為生物複合材料、聚醚醚酮（PEEK）和金屬。本報告定量分析了銷售量、手術例數、平均售價（ASP）、市場規模、成長率和企業市場占有率，並包含截至2022年的歷史數據和截至2032年的預測數據。

跟腱修復和重組是足踝醫療設備市場中的一個細分領域，其特徵是跟腱斷裂的發生率低於肩旋板斷裂和膝關節韌帶損傷等更常見的整形外科損傷。雖然老年族群中跟腱損傷的發生率正在緩慢上升，但與其他大多數整形外科領域相比，跟腱手術的總數仍然較低。

預計預測期內市場成長將保持穩定但溫和的態勢。微創手術技術的普及和先進生物相容性材料的引入是市場擴張的主要驅動力，經經皮修復系統正逐步使原本不適合手術的患者轉變為手術候選人。

市場概覽

全球跟腱修復和重組市場在足踝醫療設備領域佔有獨特的地位。與其他整形外科適應症相比，跟腱手術數量較少，這反映在其市場總規模。限制市場規模的主要阻礙因素是跟腱斷裂的發生率相對較低，以及相當一部分患者接受保守治療而非手術，尤其是在非手術復健方案較完善的地區。

在治療跟腱損傷時，選擇手術或保守治療的臨床決策仍有差異，取決於外科醫生的偏好、患者的活動水平、損傷的嚴重程度以及醫療機構的診療方案。對於許多患者群體，特別是那些久坐或運動負荷較低的患者，透過保守治療進行功能性復健仍然是首選方法。因此，手術介入仍主要集中在運動負荷較高的運動員、年輕且活躍的患者，以及需要使用先進固定裝置和增強移植物的複雜慢性重組病例。

微創和經皮修復系統的引入，正逐步擴大需要手術治療的患者群體。由於這些技術與傳統開放性手術相比，傷口併發症發生率顯著降低，跟腱修復術已成為可行的選擇，即使對於先前被建議保守治療的患者也是如此。這種轉變導致手術數量逐漸增加，尤其是在門診手術中心，因為這些中心的運作模式更注重手術時間和術後恢復速度。

生物相容性材料是該市場最重要的產品創新趨勢。從簡單的機械固定到促進生物組織再生的可吸收生物材料的轉變，正在重塑縫合錨釘的設計和移植材料的選擇。這些進步提高了臨床對修復系統的期望，尤其是在骨骼密度較低的老年患者中，這些期望體現在固定強度、生物相容性和長期治療效果等方面。

市場促進因素

足踝裝置技術的進步

足踝醫療設備領域的發展正推動可吸收生物材料和骨骼-人工植入技術的顯著進步。臨床關注正從簡單的機械固定轉向促進天然骨替代的生物整合材料，這對於骨骼密度較低的老年人群尤其重要，而生物整合對他們至關重要。預計在預測期內，足踝領域研發投入的增加將支持產品的持續創新，並推動手術數量的逐步成長，即使在總體病例數相對較低的市場中也是如此。

微創手術的普及

微創手術的興起是跟腱修復市場成長要素。與開放性手術相比，經皮修復系統顯著降低了傷口併發症的發生率，使跟腱修復成為過去被認為高風險或接受非手術治療患者的可行選擇。這擴大了符合手術條件的患者群體，從而促進了縫合錨釘和增強移植物等產品的銷售成長。支援經皮給藥的先進全縫合錨釘系統進一步推動了這一趨勢，促使製造商積極開發整合式手術包，以降低手術室操作的複雜性和差異性。

先進的外科技術和生物增強

跟腱修復領域的產業創新正日益借鑒肩關節和膝關節重組成熟的治療路徑，並越來越重視生物增強和提高固定效率。由於臨床界目前尚無公認的跟腱修復金標準，製造商擁有巨大的機會，可以圍繞專用縫合材料、生物誘導移植物和整合輸送系統，建構一個主導性的外科生態系統。那些能夠累積臨床證據並提升外科醫生認可度的公司，將更有利於塑造外科標準，並在預測期內獲得永續的市場佔有率。

市場限制

門診醫療成本削減政策

門診手術中心 (ASC) 是擇期整形外科手術的主要施行地點，由於利潤空間有限，手術耗材的價格談判異常激烈。這種壓力限制了對成本敏感的醫療機構常規使用高階生物複合材料錨釘和高成本的骨增量移植材料。較低的報銷率和獨立於醫療機構的支付政策使得低成本的 PEEK 或金屬錨釘成為許多門診手術中心預算中更現實的選擇。雖然組織移植可以提供生物增強作用，但其價格往往阻礙了其在門診手術中心的常規應用，限制了這個高價值產品類型的成長潛力，儘管其具有臨床優勢。

手術數量少

跟腱修復和重組市場從根本上受到手術較少的限制。與更常見的整形外科疾病相比，跟腱斷裂的發生率較低，而且對於久坐或運動量較小的患者，非手術功能復健的持續成功自然限制了手術數量的上限。雖然年輕且較活躍的人群中病例數量正在緩慢增加，但手術總數仍然相對較低，仍局限於小眾領域。此外，手術主要集中在高需求運動員和複雜的慢性重組中，這也限制了市場擴張，與大規模的整形外科領域相比，潛在患者範圍較小。

目錄

調查方法

• 第一步：專案推出與團隊組建
• 步驟二：資料系統開發與二次調查實施
• 步驟三：準備面試設計問卷
• 第四步：進行初步調查
• 第五步：調查分析：基準估計
• 第六步：市場預測與分析
• 第七步：辨識策略機遇
• 步驟 8：最終確認和市場公告
• 步驟九：客戶回饋與市場監測

全球關稅的影響

跟腱修復與重組市場

• 執行摘要
  • 全球阿基里斯腱修復與重組市場概覽
  • 競爭分析
  • 目標市場
  • 目標區域
• 介紹
• 手術次數
• 市場概覽
  • 按細分市場
  • 按地區
• 市場分析與預測
  • 阿基里斯腱修復重組市場整體狀況
  • 阿基里斯腱移植市場
  • 跟腱修復錨市場
• 促進因素和抑制因素
  • 市場促進因素
  • 市場限制因素
• 競爭性市佔率分析

簡稱

The global Achilles tendon repair and reconstruction market was valued at nearly $260 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.8%, reaching over $330 million by 2032.

This report covers grafts and suture anchors used in Achilles tendon repair and reconstruction procedures. Grafts are segmented by device type into allograft, xenograft, and synthetic. Suture anchors are segmented by device type into biocomposite, polyether ether ketone (PEEK), and metal. The report quantifies unit sales, procedure numbers, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.

Achilles tendon repair and reconstruction is a niche segment within the broader foot and ankle device market, defined by a low incidence rate of Achilles tendon rupture relative to more common orthopedic injuries such as rotator cuff tears or knee ligament damage. While injuries are rising modestly among active older adults, total surgical case volumes remain small compared to most other orthopedic categories.

Growth over the forecast period is expected to be steady but moderate. The transition toward minimally invasive surgical techniques and the introduction of advanced bio-integrative materials are the primary forces expanding the market, with percutaneous repair systems gradually converting historically non-operative patients into surgical candidates.

Market Overview

The global Achilles tendon repair and reconstruction market occupies a specialized position within the foot and ankle device segment. Procedural volumes are low relative to other orthopedic indications, and total market value reflects this. The primary constraint on market size is the comparatively low incidence of Achilles tendon rupture and the fact that a significant proportion of patients are managed conservatively rather than surgically, particularly in regions with established non-operative rehabilitation protocols.

Clinical decision-making between operative and conservative Achilles management remains variable and is shaped by surgeon preference, patient activity level, injury severity, and institutional protocols. Non-operative functional rehabilitation continues to be the preferred approach for many patient profiles, particularly sedentary populations and lower-demand individuals. This maintains the procedural focus on high-demand athletes, younger active patients, and cases involving complex chronic reconstructions that require advanced fixation hardware and augmentation grafts.

The introduction of minimally invasive and percutaneous repair systems is gradually expanding the surgical candidate pool. These techniques carry meaningfully lower wound complication rates compared to traditional open surgery, making Achilles repair a viable option for patients who would previously have been directed toward conservative management. This shift is adding incremental procedural volume and is most visible in ambulatory surgery center settings, where shorter procedure times and faster recovery profiles align with the operational model.

Bio-integrative materials represent the most significant product innovation trend in this market. The transition from simple mechanical fixation toward resorbable biomaterials that promote native tissue regeneration is reshaping both suture anchor design and graft selection. These advances are raising clinical expectations for what repair systems should deliver in terms of fixation strength, biological compatibility, and long-term outcomes, particularly for aging patients with lower bone density.

Market Drivers

Foot and Ankle Device Advancements

Developments in the foot and ankle device segment are driving meaningful technological progress in resorbable biomaterials and bone-prosthetic bonding techniques. The clinical focus has shifted from simple mechanical fixation toward bio-integrative materials that promote native bone replacement, with particular relevance for aging populations where lower bone density makes biological integration a priority. Increasing investment in research and development within the foot and ankle space is expected to support continued product innovation and moderate procedural volume growth over the forecast period, even within a market defined by a small overall case count.

Minimally Invasive Surgical Adoption

The transition toward minimally invasive surgery is a primary growth driver for the Achilles tendon repair market. Percutaneous repair systems significantly reduce wound complication rates compared to open surgery, making Achilles repair a practical option for patients who were previously considered higher risk or managed non-operatively. This is expanding the surgical candidate pool and supporting unit growth in suture anchor and augmentation graft categories. Advanced all-suture anchor systems compatible with percutaneous delivery formats are further supporting this trend and incentivizing manufacturers to develop integrated procedural kits that reduce complexity and variability in the operating room.

Advanced Surgical Techniques and Biological Augmentation

Industry innovation in Achilles tendon repair increasingly mirrors established pathways in shoulder and knee reconstruction, with growing emphasis on biological augmentation and improved fixation efficiency. Because no single gold standard for Achilles repair has been universally accepted across clinical communities, a meaningful opportunity exists for manufacturers to establish dominant procedural ecosystems built around specialized suture materials, bioinductive grafts, and integrated delivery systems. Companies that build clinical evidence and surgeon familiarity around their platforms are well positioned to shape procedural norms and capture durable market share over the forecast period.

Market Limiters

Cost-Saving Policies in Ambulatory Settings

Ambulatory surgery centers are the primary site for elective orthopedic procedures and operate on tight margins that drive aggressive pricing negotiation for surgical consumables. This pressure limits the routine adoption of premium biocomposite anchors and high-cost augmentation grafts in cost-sensitive facilities. Reduced reimbursement rates and site-neutral payment policies make lower-cost PEEK or metallic anchor options more practical for many ASC budgets. Tissue grafts, while providing biological reinforcement, carry a price point that often prevents routine adoption in these environments, limiting the growth potential of higher-value product categories despite their clinical advantages.

Low Procedure Volume

The Achilles tendon repair and reconstruction market is fundamentally constrained by low procedural volume. The incidence of Achilles tendon rupture is low relative to more common orthopedic conditions, and the continued success of non-operative functional rehabilitation for sedentary and lower-demand patients maintains a natural ceiling on surgical case counts. While cases are increasing modestly among younger, active demographics, total volume remains specialized and relatively small. Market expansion is further moderated by the concentration of procedures in high-demand athletes and complex chronic reconstructions, which limits the breadth of the addressable patient population compared to larger orthopedic categories.

Market Coverage and Data Scope

• Quantitative coverage: Procedure numbers, market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
• Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, disruptive technologies, and practice trends that shape demand.
• Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
• Data sources: Primary interviews with orthopedic industry leaders and foot and ankle surgeons, regulatory data, hospital and ASC procurement data, import and export data, and the iData Research internal database.
• Care settings: Hospitals, ambulatory surgery centers, and orthopedic specialty clinics.

Markets Covered and Segmentation

Graft Market

• Device type: Allograft, Xenograft, and Synthetic Grafts

Suture Anchor Market

• Device type: Biocomposite, PEEK, and Metal Suture Anchors

Each segment is analyzed by unit volume, ASP, and market value, with historical and forecast data provided.

Competitive Analysis

Arthrex was the leading competitor in the combined Achilles tendon repair and reconstruction market in 2025. The company holds a strong position in the allograft segment through its ArthroFLEX augmentation product and has built a product ecosystem around its FiberWire and FiberTape suture systems, which deliver improved knot security and a reduced knot profile compared to standard polyester sutures. Arthrex has leveraged this foundation to expand into minimally invasive surgery through its FiberTak SpeedBridge percutaneous repair system, converting historically non-operative patients into surgical candidates and creating an integrated procedural ecosystem that raises the barrier to competitive entry in high-volume surgery centers.

Stryker was the second-leading competitor in 2025. The company's strategy centers on its Citregen biomaterial platform, which has been integrated into fixation devices including the Citrelock Tendon Fixation System and the Citrefix Suture Anchor System. Citregen is designed to mimic the hydroxyapatite content of native bone and support a controlled resorption process that replaces the implant with natural tissue, reducing the chronic inflammation often associated with traditional thermoplastic implant materials. This positions Stryker at the forefront of the bio-regenerative fixation trend.

Smith and Nephew held the third-largest position in the combined market in 2025, with a focus on bio-inductive healing and knotless fixation systems. The company emphasizes the HEALICOIL REGENESORB anchor for minimally invasive Achilles procedures, which uses an open-architecture design that promotes bony ingrowth while providing high-strength fixation. This system is paired with the company's REGENETEN bioinductive implant for tissue augmentation, supporting a multi-component approach to biological repair.

Technology and Practice Trends

• Minimally invasive and percutaneous repair: Lower wound complication rates from percutaneous systems are converting non-operative patients into surgical candidates and expanding the addressable market.
• Bio-inductive and resorbable materials: The shift from mechanical fixation toward resorbable biomaterials that promote native tissue regeneration is redefining anchor design standards and graft selection criteria.
• Knotless fixation systems: Knotless anchor designs are gaining adoption for their procedural consistency, reduced chair time, and compatibility with minimally invasive delivery formats.
• High-strength suture and tape systems: Advances in suture material technology are improving fixation strength and loop security while reducing knot profiles in both open and percutaneous applications.
• ASC-compatible product design: Products engineered for faster, more cost-efficient procedures are being developed to align with the budget and workflow requirements of ambulatory surgery centers.
• Bio-integrative bone bonding: Manufacturer focus on materials that support bone-prosthetic integration addresses the challenge of reliable fixation in aging patients with reduced bone density.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• Where are the largest and fastest-growing opportunities within the global Achilles tendon repair and reconstruction market through 2032?
• How is the transition to minimally invasive and percutaneous surgery affecting procedure volumes, product selection, and the surgical candidate pool?
• Which suture anchor materials are gaining share in cost-sensitive ASC environments and what are the implications for premium biocomposite adoption?
• What role are bio-inductive grafts and resorbable biomaterials playing in product development strategies and clinical adoption rates?
• How are site-neutral payment policies and ASC pricing pressure shaping the commercial viability of higher-cost repair products?
• Which companies lead each segment and what are their product and technology roadmaps through the forecast period?
• What is the outlook for graft adoption across allograft, xenograft, and synthetic categories globally?
• What are the key risks to growth, including low procedure volume, preference for non-operative management, and reimbursement constraints across regions?

The Global Achilles Tendon Repair and Reconstruction Market Report from iData Research answers these questions with procedure-aware models, company share analysis, and pricing detail. Use it to quantify demand, benchmark competitors, prioritize product development investments, and plan for growth across all major global regions.

TABLE OF CONTENT

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Achilles Tendon Repair & Reconstruction Market

• 4.1 Executive Summary
  • 4.1.1 Global Achilles Tendon Repair & Reconstruction Market Overview
  • 4.1.2 Competitive Analysis
  • 4.1.3 Markets Included
  • 4.1.4 Regions Included
• 4.2 Introduction
• 4.3 Procedure Numbers
• 4.4 Market Overview
  • 4.4.1 By Segment
  • 4.4.2 By Region
• 4.5 Market Analysis And Forecast
  • 4.5.1 Total Achilles Tendon Repair & Reconstruction Market
  • 4.5.2 Achilles Tendon Graft Market
    • 4.5.2.1 Allograft Achilles Tendon Graft Market
    • 4.5.2.2 Xenograft Achilles Tendon Graft Market
    • 4.5.2.3 Synthetic Achilles Tendon Graft Market
  • 4.5.3 Achilles Tendon Suture Anchor Market
    • 4.5.3.1 Biocomposite Achilles Tendon Suture Anchor Market
    • 4.5.3.2 PEEK Achilles Tendon Suture Anchor Market
    • 4.5.3.3 Metal Achilles Tendon Suture Anchor Market
• 4.6 Drivers And Limiters
  • 4.6.1 Market Drivers
  • 4.6.2 Market Limiters
• 4.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 4-1: Achilles Tendon Repair & Reconstruction Market, Global, 2025 & 2032
• Chart 4-2: Achilles Tendon Repair & Reconstruction Procedures, Global, 2025
• Chart 4-3: Achilles Tendon Repair and Reconstruction Procedures by Region, Global, 2022 - 2032
• Chart 4-4: Achilles Tendon Repair & Reconstruction Market by Segment, Global, 2022 - 2032
• Chart 4-5: Achilles Tendon Repair & Reconstruction Market by Region, Global, 2022 - 2032
• Chart 4-6: Leading Competitors, Achilles Tendon Repair & Reconstruction Market, Global, 2025

LIST OF FIGURES

• Figure 4-1: Achilles Tendon Repair & Reconstruction Markets Covered
• Figure 4-2: Achilles Tendon Repair & Reconstruction Regions Covered, Global (1 of 2)
• Figure 4-3: Achilles Tendon Repair & Reconstruction Regions Covered, Global (2 of 2)
• Figure 4-4: Achilles Tendon Repair and Reconstruction Procedures by Region, Global, 2022 - 2032
• Figure 4-5: Achilles Tendon Repair and Reconstruction Procedures by Country, North America, 2022 - 2032
• Figure 4-6: Achilles Tendon Repair and Reconstruction Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 4-7: Achilles Tendon Repair and Reconstruction Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 4-8: Achilles Tendon Repair and Reconstruction Procedures by Country, Western Europe, 2022 - 2032
• Figure 4-9: Achilles Tendon Repair and Reconstruction Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 4-10: Achilles Tendon Repair and Reconstruction Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 4-11: Achilles Tendon Repair and Reconstruction Procedures by Country, Middle East, 2022 - 2032
• Figure 4-12: Achilles Tendon Repair and Reconstruction Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 4-13: Achilles Tendon Repair and Reconstruction Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 4-14: Achilles Tendon Repair and Reconstruction Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 4-15: Achilles Tendon Repair and Reconstruction Procedures by Country, Africa, 2022 - 2032
• Figure 4-16: Achilles Tendon Repair & Reconstruction Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 4-17: Achilles Tendon Repair & Reconstruction Market by Region, Global, 2022 - 2032 (US$M)
• Figure 4-18: Market Value by Region, Achilles Tendon Repair & Reconstruction Market, Global, 2022 - 2032 (US$M)
• Figure 4-19: Achilles Tendon Graft Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 4-20: Total Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-21: Units Sold by Region, Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-22: Average Selling Price by Region, Achilles Tendon Graft Market, Global, 2022 - 2032 (US$)
• Figure 4-23: Market Value by Region, Achilles Tendon Graft Market, Global, 2022 - 2032 (US$M)
• Figure 4-24: Allograft Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-25: Units Sold by Region, Allograft Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-26: Average Selling Price by Region, Allograft Achilles Tendon Graft Market, Global, 2022 - 2032 (US$)
• Figure 4-27: Market Value by Region, Allograft Achilles Tendon Graft Market, Global, 2022 - 2032 (US$M)
• Figure 4-28: Xenograft Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-29: Units Sold by Region, Xenograft Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-30: Average Selling Price by Region, Xenograft Achilles Tendon Graft Market, Global, 2022 - 2032 (US$)
• Figure 4-31: Market Value by Region, Xenograft Achilles Tendon Graft Market, Global, 2022 - 2032 (US$M)
• Figure 4-32: Synthetic Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-33: Units Sold by Region, Synthetic Achilles Tendon Graft Market, Global, 2022 - 2032
• Figure 4-34: Average Selling Price by Region, Synthetic Achilles Tendon Graft Market, Global, 2022 - 2032 (US$)
• Figure 4-35: Market Value by Region, Synthetic Achilles Tendon Graft Market, Global, 2022 - 2032 (US$M)
• Figure 4-36: Achilles Tendon Suture Anchor Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 4-37: Total Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-38: Units Sold by Region, Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-39: Average Selling Price by Region, Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$)
• Figure 4-40: Market Value by Region, Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$M)
• Figure 4-41: Biocomposite Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-42: Units Sold by Region, Biocomposite Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-43: Average Selling Price by Region, Biocomposite Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$)
• Figure 4-44: Market Value by Region, Biocomposite Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$M)
• Figure 4-45: PEEK Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-46: Units Sold by Region, PEEK Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-47: Average Selling Price by Region, PEEK Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$)
• Figure 4-48: Market Value by Region, PEEK Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$M)
• Figure 4-49: Metal Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-50: Units Sold by Region, Metal Achilles Tendon Suture Anchor Market, Global, 2022 - 2032
• Figure 4-51: Average Selling Price by Region, Metal Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$)
• Figure 4-52: Market Value by Region, Metal Achilles Tendon Suture Anchor Market, Global, 2022 - 2032 (US$M)
• Figure 4-53: Leading Competitors, Achilles Tendon Repair & Reconstruction Market, Global, 2025